Financing ·
INLIF Limited filed a 6-K attaching notice and proxy materials for an extraordinary general meeting scheduled for…
INLFINLIF Ltd
INLIF Limited filed a 6-K attaching notice and proxy materials for an extraordinary general meeting scheduled for August 17, 2026. Shareholders are voting on proposals to increase authorized share capital from US$350,000 to US$2.72 billion by creating approximately 8.5 billion new Class A and B ordinary shares. The filing also proposes reducing the par value of all ordinary shares from US$0.32 to US$0.0001 through a capital reduction and subdivision process. Additionally, shareholders will vote on adopting amended articles of association to reflect these changes and ratify Enrome LLP as the independent auditor for fiscal year 2026. INLIF Limited operates in the medical device industry, specifically focusing on minimally invasive surgical instruments.